We are live on
!
Find out more
HM
HCC Manager Portfolio holdings
AUM
$10.3M
1-Year Est. Return
6.8%
This Fund
S&P 500
This Quarter
Est. Return
-29.33%
1 Year Est. Return
+6.8%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$174M
AUM Growth
–
Cap. Flow
+$195M
Cap. Flow
% of AUM
111.82%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
2
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
+$156M |
| 2 |
Fractyl Health
GUTS
|
+$39.3M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
MC
FFGM
IVSFI
NA
FFVM
FFVM
VCG
AICPI
HCC Manager's Q1 2024 Portfolio in Review
Q1 2024 is the first quarter with a 13F filing on record for HCC Manager, which disclosed 2 positions worth $174M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Inari Medical, Inc. Common Stock: 2,914,246 shares worth $140M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets.
- HCC Manager's largest Q1 2024 buy was Inari Medical, Inc. Common Stock: 2,914,246 shares worth $140M.
- HCC Manager's ten largest holdings make up 100% of its $174M portfolio in Q1 2024.
- HCC Manager disclosed 2 positions in Q1 2024, its first 13F filing on record.
Based on HCC Manager's 13F filing for Q1 2024, filed 10 May 2024.